NAC (N-Acetyl Cysteine) moderate

NAC Dosage Guide: How Much to Take for Liver, Lungs, and Immune Support

NAC Dosage Guide: How Much to Take for Liver, Lungs, and Immune Support
TL;DR
NAC dosing ranges from 600 mg/day for general antioxidant support to 1,800-2,400 mg/day for specific clinical applications. For liver support: 1,200-1,800 mg/day. For respiratory/mucolytic use: 600-1,200 mg/day. For immune support: 1,200 mg/day. For mental health adjunctive use: 1,200-2,400 mg/day. Take on an empty stomach for best absorption. Split doses are better tolerated than single large doses. NAC is the rate-limiting substrate for glutathione synthesis — the dose determines how much glutathione your body can make.
ELI5
NAC is a supplement that helps your body make its most important antioxidant, called glutathione. The amount you should take depends on what you are using it for. For general health, about 600 milligrams a day is enough. For liver support, you need more — about 1,200 to 1,800 milligrams. For lung problems or thick mucus, 600 to 1,200 milligrams works well. It is best to take it on an empty stomach and split the dose between morning and evening.

At a Glance

PropertyValue
Evidence LevelStrong (decades of clinical use; hospital protocol for acetaminophen poisoning)
Primary UseGlutathione precursor, mucolytic, hepatoprotective, anti-inflammatory
Key MechanismProvides rate-limiting cysteine for glutathione synthesis; breaks disulfide bonds in mucus

NAC Dosage: Condition-Specific Protocols

N-acetyl cysteine is one of the most versatile compounds in clinical medicine. It is used in emergency rooms for acetaminophen poisoning, in pulmonology clinics for chronic lung disease, and increasingly in integrative and longevity medicine for its glutathione-boosting and anti-inflammatory properties.

The dose matters significantly — and it varies by application. Taking 600 mg for liver support is underdosing. Taking 2,400 mg for general antioxidant use is overdosing. Here is a condition-specific guide based on the clinical evidence.

Dosing by Application

General Antioxidant Support and Longevity

Dose: 600 mg once daily Timing: Morning, on an empty stomach Evidence: De Flora et al. demonstrated that 600 mg NAC twice weekly (not even daily) significantly reduced influenza-like episodes in elderly subjects over 6 months, suggesting meaningful immune modulation even at low doses (1). For daily general use, 600 mg provides a consistent supply of cysteine for baseline glutathione production.

Liver Support and Detoxification

Dose: 1,200-1,800 mg/day (split into 2-3 doses) Timing: 600 mg three times daily, on an empty stomach Evidence: NAC is the standard of care for acetaminophen (paracetamol) overdose — the most common cause of acute liver failure in the Western world. In overdose, NAC replenishes hepatic glutathione, which is depleted by the toxic metabolite NAPQI. For non-emergency liver support, the dose is lower but still meaningful. Khoshbaten et al. showed that 600 mg NAC three times daily for 12 weeks improved liver function tests in patients with non-alcoholic fatty liver disease (NAFLD) (2).

For alcohol consumers: If you drink regularly, NAC at 1,200 mg/day before alcohol consumption supports glutathione availability during the oxidative stress of alcohol metabolism. This does not make drinking safe — it mitigates one aspect of the damage.

Respiratory Health / Mucolytic

Dose: 600-1,200 mg/day Timing: 600 mg once or twice daily Evidence: NAC has been used as a mucolytic for decades. It breaks disulfide bonds in mucus glycoproteins, reducing viscosity and improving airway clearance. Zheng et al. meta-analyzed 13 RCTs and found that NAC (600-1,200 mg/day) reduced exacerbation frequency in COPD patients by 35-40% (3). For acute upper respiratory infections, 600-1,200 mg/day may thin secretions and speed recovery.

Immune Support

Dose: 1,200 mg/day (600 mg twice daily) Timing: Morning and evening, on an empty stomach Evidence: Glutathione is critical for lymphocyte function. T-cells and NK cells require adequate intracellular glutathione for proliferation and cytotoxic activity. NAC at 1,200 mg/day has been shown to increase lymphocyte glutathione levels by approximately 30% over 4 weeks. This is particularly relevant for older adults, whose glutathione synthesis naturally declines. For the comparison between NAC and direct glutathione supplementation, see my NAC vs. glutathione guide.

Mental Health (Adjunctive)

Dose: 1,200-2,400 mg/day Timing: Split into 2-3 doses throughout the day Evidence: This is an emerging but compelling area. NAC modulates the cystine-glutamate antiporter (system Xc-), affecting glutamate homeostasis in the brain. Clinical trials have shown benefit in:

  • OCD: 2,400 mg/day as adjunct to SSRIs showed significant symptom reduction in a 12-week RCT.
  • Addiction: 1,200-2,400 mg/day reduced cravings in cocaine, marijuana, and gambling addiction trials.
  • Depression: 1,000-2,000 mg/day as adjunct to antidepressants showed modest benefit in meta-analyses, particularly in patients with elevated inflammatory markers.
  • Bipolar disorder: 2,000 mg/day improved depressive symptoms in bipolar depression.

Important: These are adjunctive doses — used alongside, not instead of, standard psychiatric treatment. The evidence is moderate and growing, not yet definitive.

Fertility Support

Dose: 600-1,200 mg/day Timing: 600 mg once or twice daily Evidence: See my dedicated article on NAC for fertility for full details on PCOS, ovulation, and sperm quality evidence.

Post-COVID / Long COVID Support

Dose: 1,200-1,800 mg/day Timing: 600 mg two or three times daily Rationale: COVID-19 and long COVID are characterized by significant oxidative stress, glutathione depletion, and endothelial dysfunction. NAC addresses the glutathione deficit and has direct anti-inflammatory properties via NF-kB inhibition. While large-scale RCTs specifically for long COVID are limited, the mechanistic rationale is strong and the risk profile is excellent.

Dosing Summary Table

ConditionDaily DoseFrequencyDuration
General antioxidant600 mgOnce dailyOngoing
Liver support (NAFLD)1,200-1,800 mg2-3x daily12+ weeks
Alcohol liver protection1,200 mgBefore/during consumptionAs needed
Respiratory / COPD600-1,200 mg1-2x dailyOngoing
Immune support1,200 mg2x dailyOngoing
OCD (adjunctive)2,400 mg2-3x daily12+ weeks
Addiction support1,200-2,400 mg2-3x daily12+ weeks
Depression (adjunctive)1,000-2,000 mg2x daily12+ weeks
Fertility (male/female)600-1,200 mg1-2x daily3-6 months
Post-COVID support1,200-1,800 mg2-3x daily3-6 months

How to Take NAC

Empty Stomach vs. With Food

NAC is best absorbed on an empty stomach — 30 minutes before meals or 2 hours after. However, GI side effects (nausea, bloating, sulfurous taste) are the most common complaints, and taking NAC with a small amount of food significantly reduces these effects at a modest absorption cost.

My recommendation: Try on an empty stomach first. If GI effects are unacceptable, take with food. The difference in clinical effect is small compared to the difference between taking it and not taking it.

Split Dosing

Doses above 600 mg should be split. NAC has a half-life of approximately 2.5 hours, so split dosing maintains more consistent cysteine availability for glutathione synthesis. A single 1,800 mg dose produces a spike-and-crash pattern that is both less efficient and more likely to cause GI disturbance.

Synergistic Nutrients

NAC works best as part of a glutathione-support system:

  • Vitamin C (500-1,000 mg/day): Recycles oxidized glutathione (GSSG) back to reduced glutathione (GSH), extending the effective duration of glutathione in the cell.
  • Selenium (200 mcg/day): Cofactor for glutathione peroxidase, the enzyme that uses glutathione to neutralize peroxides.
  • B vitamins (especially B6, B12, folate): Support methylation pathways that interact with the transsulfuration pathway producing cysteine.

Safety and Side Effects

Common Side Effects

  • GI disturbance: Nausea, bloating, diarrhea — dose-dependent, usually mild
  • Sulfurous odor/taste: Inherent to the molecule; not a sign of poor quality
  • Headache: Occasionally reported at higher doses; usually transient

Rare but Notable

  • Bronchospasm: Reported primarily with inhaled/nebulized NAC in asthmatic patients. Oral NAC does not typically cause this, but exercise caution in severe asthma.
  • Bleeding risk: NAC has mild antiplatelet effects at high doses. Use caution in combination with anticoagulants or before surgery.

Contraindications

  • Active peptic ulcer disease: NAC may increase gastric acid secretion
  • Severe asthma (for inhaled forms only)
  • Cystinuria: NAC can increase cystine stone formation

Long-Term Safety

NAC has been used clinically for over 50 years. Long-term safety data from COPD studies (600-1,200 mg/day for years) shows an excellent safety profile. There is no evidence of toxicity or cumulative harm at recommended supplemental doses.

The Bottom Line

NAC dosing is condition-specific. The common mistake is underdosing for serious applications or overdosing for general maintenance. For most health-conscious adults without a specific clinical indication, 600 mg/day is sufficient. For liver, respiratory, immune, or mental health applications, 1,200-1,800 mg/day in divided doses is the evidence-based range. Always take on an empty stomach when possible, split doses above 600 mg, and pair with vitamin C and selenium for optimal glutathione support.

References

  1. De Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. European Respiratory Journal. 1997;10(7):1535-1541. doi:10.1183/09031936.97.10071535

  2. Khoshbaten M, Aliasgarzadeh A, Masnadi K, et al. N-acetylcysteine improves liver function in patients with non-alcoholic fatty liver disease. Hepatitis Monthly. 2010;10(1):12-16. PMID:22308119

  3. Zheng JP, Wen FQ, Bai CX, et al. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respiratory Medicine. 2014;2(3):187-194. doi:10.1016/S2213-2600(13)70286-8